Modulator: Difference between revisions

Revision as of 23:28, 4 January 2016

Nonselective MAO-A/MAO-B inhibitors
- Hydrazines
  - Isocarboxazid (Marplan)
  - Nialamide (Niamid)
  - Phenelzine (Nardil, Nardelzine)
  - Hydracarbazine
  - Benmoxin (Nerusil, Neuralex)
  - Iproclozide (Sursum)
  - Iproniazid (Marsilid, Iprozid, Ipronid, Rivivol, Propilniazida) (discontinued worldwide except for France)
  - Mebanazine (Actomol)
  - Octamoxin (Ximaol, Nimaol)
  - Pheniprazine (Catron)
  - Phenoxypropazine (Drazine)
  - Pivalylbenzhydrazine (Tersavid)
  - Safrazine (Safra)
- Other
  - Tranylcypromine (Parnate, Jatrosom)
  - Caroxazone (Surodil, Timostenil)
  - Methylene blue
  - Linezolid
Selective MAO-A inhibitors
- Harmalas
- Other
  - Bifemelane (Alnert, Celeport)
  - Moclobemide (Aurorix, Manerix)
  - Pirlindole (Pirazidol)
  - Toloxatone (Humoryl)
  - Minaprine (Cantor)
Selective MAO-B inhibitors
- Rasagiline (Azilect)
- Selegiline (Deprenyl, Eldepryl, Emsam, Zelapar)

@@ Line 1: / Line 1: @@
 __NOTOC__
+==Pharmalogical Classes==
 {| width="100%" cellspacing="10"
 |-
@@ Line 26: / Line 26: @@
 ** [[Pivalylbenzhydrazine]] (Tersavid)
 ** [[Safrazine]] (Safra)
-* Non-hydrazines
+* Other
 ** [[Tranylcypromine]] (Parnate, Jatrosom)
 ** [[Caroxazone]] (Surodil, Timostenil)
@@ Line 35: / Line 35: @@
 <li class="featured list-item">
 <h4 class="media-heading">[[Selective MAO-A inhibitors]]</h4>
-* [[Bifemelane]] (Alnert, Celeport)
+* Harmalas
-* [[Moclobemide]] (Aurorix, Manerix)
+** [[Harmine]]
-* [[Pirlindole]] (Pirazidol)
+** [[Harmaline]]
-* [[Toloxatone]] (Humoryl)
+**
-* [[Minaprine]] (Cantor)
+* Other
+** [[Bifemelane]] (Alnert, Celeport)
+** [[Moclobemide]] (Aurorix, Manerix)
+** [[Pirlindole]] (Pirazidol)
+** [[Toloxatone]] (Humoryl)
+** [[Minaprine]] (Cantor)
 </li>